{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:34:50Z","timestamp":1793885690893,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s11095-011-0430-9","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T18:12:49Z","timestamp":1301076769000},"page":"2045-2054","source":"Crossref","is-referenced-by-count":37,"title":["Increased Liver Uptake and Reduced Hepatic Stellate Cell Activation with a Cell-Specific Conjugate of the Rho-kinase Inhibitor Y27632"],"prefix":"10.1007","volume":"28","author":[{"given":"Marike Marjolijn","family":"van Beuge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Reker-Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Beljaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas","family":"Poelstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,26]]},"reference":[{"issue":"9615","key":"430_CR1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"371","author":"D Schuppan","year":"2008","unstructured":"Schuppan D, Afdhal N. Liver cirrhosis. Lancet. 2008;371(9615):838\u201351.","journal-title":"Lancet"},{"issue":"1","key":"430_CR2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11894-009-0080-9","volume":"12","author":"A Thompson","year":"2010","unstructured":"Thompson A, Patel K. Antifibrotic therapies: will we ever get there? Curr Gastroenterol Rep. 2010;12(1):23\u20139.","journal-title":"Curr Gastroenterol Rep"},{"issue":"4","key":"430_CR3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cld.2008.07.007","volume":"12","author":"YS Lim","year":"2008","unstructured":"Lim YS, Kim WR. The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis. 2008;12(4):733\u201346. vii.","journal-title":"Clin Liver Dis"},{"issue":"6","key":"430_CR4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1478-3231.2010.02264.x","volume":"30","author":"D Schuppan","year":"2010","unstructured":"Schuppan D, Gorrell M, Klein T, Mark M, Afdhal N. The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis. Liver Int. 2010;30(6):795\u2013808.","journal-title":"Liver Int"},{"issue":"1","key":"430_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88(1):125\u201372.","journal-title":"Physiol Rev"},{"issue":"6","key":"430_CR6","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134(6):1655\u201369.","journal-title":"Gastroenterology"},{"issue":"3","key":"430_CR7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/hep.510280336","volume":"28","author":"HF Yee","year":"1998","unstructured":"Yee HF. Rho directs activation-associated changes in rat hepatic stellate cell morphology via regulation of the actin cytoskeleton. Hepatology. 1998;28(3):843\u201350.","journal-title":"Hepatology"},{"issue":"2","key":"430_CR8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/BJ20061432","volume":"401","author":"PG Charest","year":"2007","unstructured":"Charest PG, Firtel RA. Big roles for small GTPases in the control of directed cell movement. Biochem J. 2007;401(2):377\u201390.","journal-title":"Biochem J"},{"issue":"10","key":"430_CR9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00109-002-0370-2","volume":"80","author":"N Wettchureck","year":"2002","unstructured":"Wettchureck N, Offermanns S. Rho\/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med. 2002;80(10):629\u201338. 2007\/06.","journal-title":"J Mol Med"},{"issue":"6","key":"430_CR10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrm1128","volume":"4","author":"K Riento","year":"2004","unstructured":"Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2004;4(6):446\u201356.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"430_CR11","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1440-1746.2006.04735.x","volume":"22","author":"K Kitamura","year":"2007","unstructured":"Kitamura K, Tada S, Nakamoto N, Toda K, Horikawa H, Kurita S, et al. Rho\/Rho kinase is a key enzyme system involved in the angiotenin II signaling pathway of liver fibrosis and steatosis. J Gastroenterol Hepatol. 2007;22(11):2022\u201333.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"430_CR12","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0168-8278(01)00169-6","volume":"35","author":"T Murata","year":"2001","unstructured":"Murata T, Arii S, Nakamura T, Mori A, Kaido T, Furuyama H, et al. Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells. J Hepatol. 2001;35(4):474\u201381.","journal-title":"J Hepatol"},{"issue":"1","key":"430_CR13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0041-1345(02)03903-9","volume":"35","author":"K Mizunuma","year":"2003","unstructured":"Mizunuma K, Ohdan H, Fudaba Y, Tashiro H, Asahara T. ROCK inhibitor, Y-27632, inhibits anoxia-reoxygenation-induced contraction of hepatic stellate cells. Transplant Proc. 2003;35(1):111\u20133.","journal-title":"Transplant Proc"},{"issue":"3","key":"430_CR14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/BF02256455","volume":"10","author":"P Tangkijvanich","year":"2003","unstructured":"Tangkijvanich P, Melton AC, Santiskulvong C, Yee HF. Rho and p38 MAP kinase signaling pathways mediate LPA-stimulated hepatic myofibroblast migration. J Biomed Sci. 2003;10(3):352\u20138.","journal-title":"J Biomed Sci"},{"issue":"5","key":"430_CR15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0168-8278(00)80245-7","volume":"32","author":"H Iwamoto","year":"2000","unstructured":"Iwamoto H, Nakamuta M, Tada S, Sugimoto R, Enjoji M, Nawata H. A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth. J Hepatol. 2000;32(5):762\u201370.","journal-title":"J Hepatol"},{"issue":"4","key":"430_CR16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1478-3231.2005.01142.x","volume":"25","author":"M Fukushima","year":"2005","unstructured":"Fukushima M, Nakamuta M, Kohjima M, Kotoh K, Enjoji M, Kobayashi N, et al. Fasudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells. Liver Int. 2005;25(4):829\u201338.","journal-title":"Liver Int"},{"issue":"1","key":"430_CR17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0022-4804(03)00202-6","volume":"114","author":"T Murata","year":"2003","unstructured":"Murata T, Arii S, Mori A, Imamura M. Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on the established liver fibrosis. J Surg Res. 2003;114(1):64\u201371.","journal-title":"J Surg Res"},{"issue":"4","key":"430_CR18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0168-8278(00)00059-3","volume":"34","author":"S Tada","year":"2001","unstructured":"Tada S, Iwamoto H, Nakamuta M, Sugimoto R, Enjoji M, Nakashima Y, et al. A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats. J Hepatol. 2001;34(4):529\u201336.","journal-title":"J Hepatol"},{"issue":"3","key":"430_CR19","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1053\/j.gastro.2005.11.029","volume":"130","author":"M Hennenberg","year":"2006","unstructured":"Hennenberg M, Biecker E, Trebicka J, Jochem K, Zhou Q, Schmidt M, et al. Defective RhoA\/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats. Gastroenterology. 2006;130(3):838\u201354.","journal-title":"Gastroenterology"},{"issue":"5","key":"430_CR20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrc2106","volume":"7","author":"T Force","year":"2007","unstructured":"Force T, Krause DS, van Etten RA. Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nat Rev Cancer. 2007;7(5):332\u201344.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"430_CR21","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.510290526","volume":"29","author":"L Beljaars","year":"1999","unstructured":"Beljaars L, Molema G, Weert B, Bonnema H, Olinga P, Groothuis GM, et al. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells. Hepatology. 1999;29(5):1486\u201393.","journal-title":"Hepatology"},{"key":"430_CR22","first-page":"1429","volume":"21","author":"P Bleser de","year":"1995","unstructured":"de Bleser P, Jannes P, van Buul-Offers SC, Hoogerbrugge CM, van Schravendijk CFH, Niki T, et al. Insulin like Growth Factor-II\/Mannose 6-Phosphate receptor is expressed on CCl4-exposed rat fat-storing cells and facilitates activation of latent transfroming growth factor-\u00df in cocultures with sinusoidal endothelial cells. Hepatology. 1995;21:1429\u201337.","journal-title":"Hepatology"},{"issue":"8","key":"430_CR23","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s11095-006-9025-2","volume":"23","author":"R Greupink","year":"2006","unstructured":"Greupink R, Bakker HI, van Goor H, de Borst MH, Beljaars L, Poelstra K. Mannose-6-phosphate\/insulin-Like growth factor-II receptors may represent a target for the selective delivery of mycophenolic acid to fibrogenic cells. Pharm Res. 2006;23(8):1827\u201334.","journal-title":"Pharm Res"},{"key":"430_CR24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrm1050","volume":"4","author":"P Ghosh","year":"2003","unstructured":"Ghosh P, Dahms NM, Kornfeld S. Mannose 6-phosphate receptors: new twists in the tale. Nat Rev Mol Cell Biol. 2003;4:202\u201312.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"430_CR25","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1681\/ASN.2007070794","volume":"19","author":"J Prakash","year":"2008","unstructured":"Prakash J, de Borst MH, Lacombe M, Opdam F, Klok PA, van Goor H, et al. Inhibition of renal rho kinase attenuates ischemia\/reperfusion-induced injury. J Am Soc Nephrol. 2008;19:2086\u201397.","journal-title":"J Am Soc Nephrol"},{"key":"430_CR26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1034\/j.1600-0676.2001.210504.x","volume":"21","author":"L Beljaars","year":"2001","unstructured":"Beljaars L, Olinga P, Molema G, de Bleser P, Geerts A, Groothuis GM, et al. Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P28-HSA). Liver. 2001;21:320\u20138.","journal-title":"Liver"},{"issue":"2","key":"430_CR27","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.510270238","volume":"27","author":"A Geerts","year":"1998","unstructured":"Geerts A, Niki T, Hellemans K, De Craemer D, Van Den Berg K, Lazou J, et al. Purification of rat hepatic stellate cells by side scatter-activated cell sorting. Hepatology. 1998;27(2):590\u20138.","journal-title":"Hepatology"},{"issue":"1","key":"430_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033583508004745","volume":"42","author":"LN Johnson","year":"2009","unstructured":"Johnson LN. Protein kinase inhibitors: contributions from structure to clinical compounds. Q Rev Biophys. 2009;42(1):1\u201340.","journal-title":"Q Rev Biophys"},{"issue":"3","key":"430_CR29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2001-17550","volume":"21","author":"A Geerts","year":"2001","unstructured":"Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Sem Liver Dis. 2001;21(3):311\u201334.","journal-title":"Sem Liver Dis"},{"issue":"3","key":"430_CR30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2001-17552","volume":"21","author":"RC Benyon","year":"2001","unstructured":"Benyon RC, Arthur MJ. Extracellular matrix degradation and the role of hepatic stellate cells. Sem Liver Dis. 2001;21(3):373\u201384.","journal-title":"Sem Liver Dis"},{"issue":"9","key":"430_CR31","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/gut.2005.081059","volume":"55","author":"Q Zhou","year":"2006","unstructured":"Zhou Q, Hennenberg M, Trebicka J, Jochem K, Leifeld L, Biecker E, et al. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Gut. 2006;55(9):1296\u2013305.","journal-title":"Gut"},{"issue":"2","key":"430_CR32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/hep.21502","volume":"45","author":"M Hennenberg","year":"2007","unstructured":"Hennenberg M, Trebicka J, Biecker E, Schepke M, Sauerbruch T, Heller J. Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins. Hepatology. 2007;45(2):495\u2013506.","journal-title":"Hepatology"},{"issue":"1","key":"430_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874467210801010001","volume":"1","author":"K Temming","year":"2008","unstructured":"Temming K, Fretz MM, Kok RJ. Organ and cell-type specific delivery of kinase inhibitors: a novel approach in the development of targeted drugs. Curr Mol Pharmacol. 2008;1(1):1\u201312.","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"430_CR34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/jpet.106.106054","volume":"319","author":"J Prakash","year":"2006","unstructured":"Prakash J, Sandovici M, Saluja V, Lacombe M, Schaapveld RQ, de Borst MH, et al. Intracellular delivery of the p38 mitogen-activated protein kinase inhibitor SB202190 [4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1 H-imidazole] in renal tubular cells: a novel strategy to treat renal fibrosis. J Pharmacol Exp Ther. 2006;319(1):8\u201319.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"430_CR35","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1124\/jpet.106.114496","volume":"321","author":"T Gonzalo","year":"2007","unstructured":"Gonzalo T, Beljaars L, van de Bovenkamp M, Temming K, van Loenen AM, Reker-Smit C, et al. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells. J Pharmacol Exp Ther. 2007;321(3):856\u201365.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"430_CR36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","volume":"117","author":"J Iredale","year":"2007","unstructured":"Iredale J. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest. 2007;117(3):539\u201348.","journal-title":"J Clin Invest"},{"issue":"1","key":"430_CR37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1074\/jbc.M005505200","volume":"276","author":"CP Mack","year":"2001","unstructured":"Mack CP, Somlyo AV, Hautmann M, Somlyo AP, Owens GK. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem. 2001;276(1):341\u20137.","journal-title":"J Biol Chem"},{"issue":"5","key":"430_CR38","doi-asserted-by":"crossref","first-page":"G880","DOI":"10.1152\/ajpgi.00039.2003","volume":"285","author":"H Ikeda","year":"2003","unstructured":"Ikeda H, Nagashima K, Yanase M, Tomiya T, Arai M, Inoue Y, et al. Involvement of Rho\/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2003;285(5):G880\u20136.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"430_CR39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ceb.2008.01.002","volume":"20","author":"MF Olson","year":"2008","unstructured":"Olson MF. Applications for ROCK kinase inhibition. Curr Opin Cell Biol. 2008;20:242\u20138.","journal-title":"Curr Opin Cell Biol"},{"issue":"1\u20132","key":"430_CR40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2005.12.010","volume":"111","author":"T Gonzalo","year":"2006","unstructured":"Gonzalo T, Talman EG, van de Ven A, Temming K, Greupink R, Beljaars L, et al. Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technology. J Control Release. 2006;111(1\u20132):193\u2013203.","journal-title":"J Control Release"},{"issue":"3","key":"430_CR41","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/hep.23421","volume":"51","author":"M Moreno","year":"2010","unstructured":"Moreno M, Gonzalo T, Kok RJ, Sancho-Bru P, van Beuge M, Swart J, et al. Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats. Hepatology. 2010;51(3):942\u201352.","journal-title":"Hepatology"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-011-0430-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T17:31:21Z","timestamp":1497893481000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-011-0430-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,26]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["430"],"URL":"https:\/\/doi.org\/10.1007\/s11095-011-0430-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718874823.793499782","asserted-by":"object"}]},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,26]]}}}